Zero Breast Cancer at CHE

Zero Breast Cancer at CHE

Civic and Social Organizations

San Rafael, CALIFORNIA 348 followers

Envisioning zero breast cancer as a project of Collaborative for Health & Environment (CHE)

About us

Zero Breast Cancer promotes breast cancer risk reduction through translation of scientific research and evidence-based recommendations that support health and wellness at key stages of life. We envision a world with zero breast cancer.

Industry
Civic and Social Organizations
Company size
2-10 employees
Headquarters
San Rafael, CALIFORNIA
Type
Nonprofit
Founded
1996
Specialties
Breast Cancer, Breast Cancer Research, and Breast Cancer Prevention Education & Awareness

Locations

Employees at Zero Breast Cancer at CHE

Updates

  • Check out Zero Breast Cancer's latest blog article by Collaborative for Health & Environment Science Communications Intern Dr. Bridget Martin on a groundbreaking study about chemical mixtures and breast cancer risk: https://lnkd.in/g7EG6M6r -- Chemicals linked to breast cancer risk come from many sources: our personal care products, cleaning supplies, food packaging, pesticides, the air we breathe, the water we drink, and more. These chemicals, including endocrine disrupting chemicals and mammary gland carcinogens, can alter vital pathways in our bodies. While most research has focused on single chemicals, in reality, we are not exposed to chemicals one at a time. We are exposed to many chemicals at the same time throughout our daily lives. Chemical mixtures are combinations of two or more chemicals that can interact with each other and their surroundings, leading to unique effects on human health and the environment. It is not known whether exposures to chemical mixtures have a larger effect on breast cancer risk than exposure to single chemicals. Research is needed to determine whether breast cancer risk is higher depending on the type and amount of chemical mixtures an individual is exposed to, and which chemical mixtures are most impactful. A groundbreaking new study led by Dr. Kimberly Badal seeks to uncover the links between exposure to chemical mixtures and the risk of breast cancer. The study will also compare exposures between women who live in neighborhoods with high vs. low levels of socioeconomic disadvantage. Read more by following the link above.

    A Groundbreaking Study on Chemical Mixtures and Breast Cancer Risk

    A Groundbreaking Study on Chemical Mixtures and Breast Cancer Risk

    zerobreastcancer.org

  • Are you ready to take charge of your health and well-being after completing active breast cancer treatment? Our Resilient Me Health & Wellness Coaching Program is designed to support you in thriving. In Resilient Me, clients are paired with a certified coach to work on recurrence risk reduction goals related to physical activity, diet, sleep, managing stress, and/or limiting exposure to toxic chemicals. Clients and coaches work together for 12 Zoom sessions that are each 30 minutes long. We have funding to serve people in Northern California with an emphasis on the greater San Francisco Bay Area. More information and a link to the application are available at https://lnkd.in/gS7eH5n8.

    • No alternative text description for this image
  • We hope you will join us 10/29 at 12 pm PT for a free webinar "Breast Cancer, Diet, and Heart Health: How the Pathways Study is Informing Lifestyle Medicine." Register at zbclink.org/pathwaysforum4 Isaac Ergas, PhD (Kaiser Permanente Northern California Division of Research), will highlight how recent findings from the Pathways Study reveal the role of diet quality in lowering the risk of heart disease in breast cancer survivors. Robin Zwerling Baltrushes, MD (Kaiser Permanente), will explore the role of lifestyle medicine in supporting survivors and provide practical solutions for improving long-term health. Lianna Hartmour, MA (Zero Breast Cancer at Collaborative for Health & Environment), will host the forum and lead the Q&A with the two researchers and Pathways Principal Investigator Larry Kushi, ScD (Kaiser Permanente Northern California Division of Research).

    • No alternative text description for this image
  • Zero Breast Cancer is proud to now be a project of Collaborative for Health & Environment (CHE)! Learn more in the blog shared by CHE. We're excited that ZBC will continue all of our programs while being strengthened by this new partnership!

    We’re pleased to announce that Zero Breast Cancer (ZBC) is now a project of CHE! "This new partnership is rooted in our shared commitment to translating science into action in the service of health." - Kristin Schafer, CHE Director "I’m grateful that all of our programs will continue to reach a wide audience – from young kids through survivors — to promote breast cancer risk reduction and survivor health and wellness.” Lianna Hartmour, Program & Communications Director, Zero Breast Cancer at CHE Find out more about our new partnership at the link below! https://lnkd.in/grunGTiB

    Zero Breast Cancer joins CHE

    Zero Breast Cancer joins CHE

    healthandenvironment.org

  • We're now enrolling people after active breast cancer treatment in the greater San Francisco Bay Area for free health and wellness coaching! Learn more and apply at zbclink.org/HWCsummer2024 Are you ready to take charge of your health and well-being after completing active breast cancer treatment? Our Resilient Me Health & Wellness Coaching Program is designed to support you in thriving. Your certified coach will help you develop sustainable lifestyle changes where you can improve your health and wellness, cope with treatment side effects and reduce the risk of recurrence (likelihood of getting breast cancer again) or maximize the likelihood of positive outcomes with a breast cancer diagnosis (like improved quality of life, well-being, and length of life).

    • No alternative text description for this image
  • It's not too late to sign up for our free webinar TOMORROW, 4/25, 11 AM PDT/2 PM EDT. After the presentations by a researcher and a clinician, Pathways study Principal Investigator Larry Kushi, ScD, will join to answer your questions. Learn more below and register at zbclink.org/pathwaysforum3 How do genes impact breast cancer risk and treatment? Do lifestyle and environment matter for genetic risk? How is genetic information used by physicians? Get these questions and more answered in our hour-long free webinar. Christine Ambrosone, PhD (Roswell Park Comprehensive Cancer Center), will explain how common genetic variations may impact breast cancer risk when they occur with known lifestyle and environmental cancer risk factors and how the Pathways Survivorship Study has ongoing and planned research on these types of genetic variations. Leslie Manace, MD, MPhil (Kaiser Permanente), will explain how genetic testing is relevant for precision medicine to benefit people with hereditary cancer risk and their relatives, and for personalized information regarding tumor prognosis and treatment options. After their presentations, they will be joined by Pathways study Principal Investigator Larry Kushi, ScD, to answer your questions. This webinar is for anyone interested, including: - People with a diagnosis or history of breast cancer, including metastatic disease - Those who care for or about someone diagnosed with breast cancer - Healthcare providers and social workers serving people with cancer - Public health professionals and researchers

    • No alternative text description for this image
  • Don't forget to register for our free webinar "Genetics & Breast Cancer: Learnings from the Pathways Study and Clinical Practice"! It will take place this Thursday, 4/25, 11 am PDT/2 pm EDT. Register at zbclink.org/pathwaysforum3 Learn more about one of the talks below: Clinical Genomics in Cancer Care: With innovation in precision medicine, health systems are increasingly motivated to improve access to genetic testing--both for discovering rare hereditary predispositions to benefit people affected with cancer and their relatives, and for personalized information regarding tumor prognosis and treatment options. Availability of genetic testing at the point of diagnosis, as well as in preventive settings, has been a public health genomics priority for 20 years; however implementation of this is ongoing. New clinical approaches and technology tools are needed to improve access to genomic health information. Leslie Manace MD, MPhil, leads Kaiser Permanente Northern California's hereditary cancer care and precision medicine & genomics innovation, and will speak to the landscape of clinical cancer genomics today.

    • No alternative text description for this image
  • We hope you will come to our webinar this Thursday, 4/25, at 11 am PDT/2 pm EDT to learn about genetics and breast cancer! Register at zbclink.org/pathwaysforum3 Learn more about one of the talks below. Role of Genetics in Cancer Risk and Outcomes in The Pathways Study: Unlike inherited genetic mutations that are fairly rare in populations but result in substantial increases in risk of breast cancer among those who carry those mutations (like BRCA1 and BRCA2), there are common genetic variations that may only increase risk when they occur along with known cancer risk factors. Similarly, these common genetic differences may also affect how well cancer therapies can kill cancer cells and also how severe side effects from those treatments may be. Christine Ambrose, PhD, a Pathways researcher at Roswell Park Comprehensive Cancer Center will explain these concepts and give some examples of ongoing and planned research studying these types of genetic variants in the Pathways Study.

    • No alternative text description for this image

Similar pages